While prior literature classifies AP3B2 antibody-associated sensory disturbances as sensory neuropathy (4), we propose that cases presenting solely with sensory deficits (e.g., limb numbness) should be more appropriately classified as AP3B2 antibody-associated SN to reflect precise clinicopathological correlation. This evidence concerns the gene AP3B2 and sensory peripheral neuropathy.